Karen Rowlandson

Health Canada

Dr. Rowlandson is a Senior Scientific Evaluator with the Centre for the Evaluation of Radiopharmaceuticals and Biologics (CERB) in the Biologic and Radiopharmaceutical Drugs Directorate (BRDD) at Health Canada. She holds a PhD in Microbiology and Immunology from the University of Ottawa. Her PhD research explored the development of a plant-derived vaccine for cytomegalovirus. After several years as a reviewer in the Bacterial and Combination Vaccine Division of BRDD, Karen joined CERB, where she continues to be a CMC evaluator of biotherapeutic products. While in CERB, she has participated in and led many On-Site Evaluations. In her spare time, she enjoys camping with her family and biking with friends.


This speaker has made no appearances.